Analyse
Fundierte Analysen zu Pharmamärkten, Lieferketten, Technologie und Regulierung
#supply chain ×
Analyse
28. Sept. 2026•1 Min. Lesezeit
Pharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
South Korean pharmaceutical distributors announce order cut‑off dates of Sep 21‑23 before the Chuseok holiday, with shipments resuming on Sep 28.
4
Analyse
24. Sept. 2026•1 Min. Lesezeit
Oseltamivir Suspension Powder Faces Supply Shortage Amid Rapid Flu Spread in Korea
Pharmacies report stockouts of pediatric oseltamivir suspension powder as influenza cases surge; some manufacturers still hold inventory, but supply pressure is rising.
Analyse
19. Sept. 2026•1 Min. Lesezeit
Samnam Pharmaceutical’s Magmil Leads August Pharmacy Restock Alerts in Korea
Magmil tablets from Samnam Pharmaceutical recorded the highest number of out‑of‑stock restock requests in August, with 26,673 alerts, according to BRPConnect data.
Analyse
17. Sept. 2026•1 Min. Lesezeit
KDCA assures timely supply of 12.33 million influenza NIP doses despite Sanofi delay
The Korea Disease Control and Prevention Agency says the 12.33 million influenza vaccine doses for the 2026‑2027 national immunization program will be delivered on schedule, despite early supply delays from Sanofi.
Analyse
12. Sept. 2026•1 Min. Lesezeit
Co‑promotion contracts end for major drugs, prompting distribution shift in Korea
Major co‑promotion agreements with Jongkundang are ending, shifting supply to sole distributors and other pharma firms, prompting pharmacies to tighten inventory controls.
Analyse
9. Sept. 2026•1 Min. Lesezeit
Daewon Pharmaceutical Continues Production and Supply of Cough Expectorant ‘Kodaewon‑Jeong’
Daewon Pharmaceutical announced it will keep producing and distributing its cough expectorant ‘Kodaewon‑Jeong’ without any supply interruption, citing patient convenience and prescription clarity.
Analyse
7. Sept. 2026•1 Min. Lesezeit
KPA and Paju City Sign MOU to Build Joint Pharma Logistics Hub in Peace Economic Zone
The Korean Pharmaceutical Distribution Association and Paju city have signed an MOU to develop a 100,000‑pyeong pharmaceutical and biotech logistics complex within the Paju Peace Economic Zone.
Analyse
5. Sept. 2026•1 Min. Lesezeit
Jeil Pharm focuses Zaqubo production as Quzetas and Oncap halted, raising supply concerns
Domestic P‑CAB drug Zaqubo climbs to second market share, while Jeil Pharm stops production of twin Jastafrazan products Quzetas and Oncap, leaving their future supply uncertain.
Analyse
5. Sept. 2026•1 Min. Lesezeit
EasyMedicom partners with ISM Korea to launch CHSCA and CHSCM certifications in Korea
EasyMedicom and ISM Korea are introducing ISCEA‑certified CHSCA and CHSCM healthcare supply‑chain qualifications in South Korea to develop local expertise.
Analyse
1. Sept. 2026•1 Min. Lesezeit
Samjin Pharma to Normalize HydraSec Supply After MFDS Pediatric Indication Withdrawal
Following MFDS removal of pediatric use for diacetyl hexyl smectite, demand shifted to HydraSec, causing shortages; Samjin Pharma expects supply normalization this week.
Analyse
31. Aug. 2026•1 Min. Lesezeit
GC Green Cross and Korea Vaccine Sign MOU for Vaccine CMO Collaboration
GC Green Cross and Korea Vaccine have signed an MOU to cooperate on contract manufacturing of vaccines, including prefilled syringe production and diversification of flu‑vaccine output.
Analyse
30. Aug. 2026•1 Min. Lesezeit
Pharma distributors adjust schedules for July 17 Constitution Day
Pharma distributors in South Korea are changing delivery dates around the July 17 Constitution Day holiday; pharmacies should check each supplier’s cut‑off times to avoid order issues.